Shitanshu Uppal

OV-HIPEC 1: Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer

The addition of HIPEC to interval cytoreductive surgery for stage III epithelial ovarian cancer significantly improves recurrence-free and overall survival without an increase in severe side effects.

Fertility Preservation in EIN/CAH

Fertility Preservation in EIN/CAH and Grade 1/2 endometrial Cancer

Publications Update # 54

The investment answer, surrogate endpoints in oncology, GOG-279 and A18 in cervical cancer

GOG 279: Cisplatin, Gemcitabine, and IMRT for Locally Advanced Vulvar Carcinoma

Weekly Cisplatin and Gemcitabine concurrent with IMRT improved CPR in women with locally advanced vulvar squamous cell carcinoma not amenable to surgical resection.

Surgical Management of Complex Endometrial Hyperplasia/EIN

Surgical Management of EIN/CAH

GOG 261: Paclitaxel and Carboplatin Versus Paclitaxel and Ifosfamide in Carcinosarcoma

Carboplatin/Taxol is not inferior to Ifos/Taxol in terms of OS and significantly increases PFS, making it a new standard treatment for carcinosarcoma

Publications Update # 53

HER-2 testing in gynecologic cancers, prognostic role of ITCs in low-grade endometrial cancer, primary cytoreduction in ovarian cancer.

Climate -

Read more on how Stripe helps GYOEDU contribute towards carbon

Publications Update # 52

Becoming G.O.A.T by adopting a goat's mentality, 3+3 clinical trial design, vulvar cancer groin node management and the risk of ovarian metastasis in endometrial cancer patients less than 50

Publications Update # 51

CALLA trial, Keynote-A18, myoinvasive or non-myoinvasive p53 abn stage 1A endometrial cancer and the effect of isolation on humans